Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mostly Medicaid is a U.S.-based Medicaid-focused advisory, consulting, research, and media company serving health plans, government agencies, technology vendors, and pharmaceutical and device manufacturers operating in the Medicaid market. The firm publishes Medicaid industry news, interviews, podcasts, and educational content while also providing management consulting, procurement support, market-entry strategy, operational improvement, and policy-related advisory services. Its positioning is centered on being a trusted specialist in the Medicaid and broader public health and human services ecosystem rather than a drug-development company. The company also appears to operate a broader family of Medicaid-focused businesses and has expanded through at least one tuck-in acquisition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mostly Medicaid.